Zuo, Yantao
Mukhin, Alexey G.
Berg, Hannah
Morgan, Janiece D.
Mintz, Akiva
Rose, Jed E.
Solingapuram Sai, Kiran Kumar
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA044756, R01DA044756, R01DA044756, R01DA044756, R01DA044756, R01DA044756)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01DA044756)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
Article History
Received: 23 May 2022
Revised: 17 July 2022
Accepted: 22 July 2022
First Online: 12 August 2022
Competing interests
: AGM discloses grants from the National Institute on Drug Abuse and consulting for Rose Research Center LLC on the project funded by Philip Morris International, outside the submitted work. JER discloses grants from the National Institute on Drug Abuse, research support from Foundation for a Smoke-Free World, Philip Morris International, Altria, JUUL Labs, consulting with Revive pharmaceuticals, and consulting and patent purchase agreement with Philip Morris International, related to smoking cessation and tobacco harm reduction. All other authors declare no competing interests.